Teva Pharmaceutical Industries (TEVA)

Add to Watchlists Create an Alert
39.34 -0.15  -0.38%   NYSE May 24, 8:00PM BATS Real time Currency in USD

Teva Pharmaceutical Industries Net Income Quarterly:

630.00M for March 31, 2013
View Full Chart

Teva Pharmaceutical Industries Net Income Quarterly Chart

    Teva Pharmaceutical Industries Historical Net Income Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 3   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 630.00M
    Dec. 31, 2012 320.00M
    Sept. 30, 2012 -79.00M
    June 30, 2012 863.00M
    March 31, 2012 859.00M
    Dec. 31, 2011 506.00M
    Sept. 30, 2011 916.00M
    June 30, 2011 576.00M
    March 31, 2011 761.00M
    Dec. 31, 2010 771.00M
    Sept. 30, 2010 1.05B
    June 30, 2010 797.00M
    March 31, 2010 713.00M
    Dec. 31, 2009 379.00M
    Sept. 30, 2009 649.00M
    June 30, 2009 521.00M
    March 31, 2009 451.00M
    Dec. 31, 2008 -688.00M
    Sept. 30, 2008 637.00M
    June 30, 2008 539.00M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Net Income

    Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

    Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
    Learn More

    Get data for

    TEVA Net Income Quarterly Benchmarks

    Companies
    Pfizer 2.75B
    Mylan 106.88M
    Alexza Pharmaceuticals -20.71M

    TEVA Net Income Quarterly Rankings

    Overall 97th percentile
    187 of 8011
    Sector 97th percentile
    16 of 687 in Healthcare
    Industry 98th percentile
    1 of 69 in Drug Manufacturers - Specialty & Generic

    TEVA Net Income Quarterly Range, Past 5 Years

    Minimum -688.00M Dec 2008
    Maximum 1.05B Sep 2010
    Average 558.55M